Pigmented villonodular synovitis (PVNS) is a rare proliferative and destructive disorder involving the synovium of joint capsules, tendon sheaths, and bursae. The estimated annual incidence of PVNS is 1.8 patients per million individuals, and young and middle-aged adults are the most frequently affected ([@CIT0013]). PVNS is usually a monoarticular condition, the predominant site being the knee followed by the hip and ankle ([@CIT0006]). The etiology and pathogenesis of PVNS are unknown, but it may be due to chronic inflammation ([@CIT0014]) or a neoplastic process ([@CIT0004], [@CIT0021]).

There are two distinct forms of PVNS, localized and diffuse, based on the extent of synovial involvement ([@CIT0006], [@CIT0013]). The two forms are histologically similar, but diffuse PVNS presents with more pronounced symptoms and is more rapidly destructive with a tendency to invade extra-articular structures such as muscles, tendons, bones, neurovascular structures, and skin ([@CIT0006], [@CIT0016]). Whereas successful local control can be achieved by excision of localized masses ([@CIT0006], [@CIT0019]), complete tumor removal in patients with the diffuse form may be more difficult, with recurrence rates after surgery alone ranging from 8% to 56% depending on the extent of surgery ([@CIT0020], [@CIT0015], [@CIT0005], [@CIT0023]). Postoperative radiotherapy (RT) has been used to achieve better local control in patients with primary or recurrent PVNS ([@CIT0016], [@CIT0002], Chin et a. 2002, [@CIT0011], [@CIT0001], [@CIT0008], [@CIT0007]).

It is unclear whether treatment outcomes are influenced by the location of the disease or the radiation dose. PVNS of the knee is, however, associated with a higher recurrence rate than PVNS at other joints ([@CIT0020]). Moreover, there have been no studies on radiation dose-response relationships to date. At Asan Medical Center, patients have been given the conventional dose (32--34 Gy) or a lower dose (20 Gy) as postoperative treatment for diffuse PVNS of the knee, depending on the views of treating physicians who favored different pathogenesis theories---neoplasia or chronic inflammation. We retrospectively compared the clinical outcomes of patients who were treated with conventional or low-dose RT.

Patients and methods {#ss2}
====================

Patient characteristics {#ss3}
-----------------------

We retrospectively reviewed the medical records of 23 consecutive patients who received external beam RT after synovectomy for diffuse PVNS of the knee at Asan Medical Center between 1998 and 2007 ([Table 1](#T1){ref-type="table"}). The diagnosis in all patients was confirmed histopathologically. Median age was 37 (10--64) years and 15 patients were female. Pain and swelling of the affected knee were the predominant symptoms, with median duration of symptoms of 1.5 (0.5--10) years. 4 patients received postoperative RT for recurrent disease, with 2--3 prior surgeries. MRI was performed in all patients at the initial diagnosis, and at follow-up in 15 patients.

###### 

Patient and treatment characteristics

  A    B    C   D     E    F   G    H    I     J    K         L     M
  ---- ---- --- ----- ---- --- ---- ---- ----- ---- --------- ----- -----------
   1   28   M   No    P    A   R0   16   No                   9     Good
   2   48   M   No    P    A   R0   20   No                   141   Good
   3   14   M   Yes   P    A   R0   20   No                   140   Excellent
   4   25   F   No    P    A   R2   20   No                   140   Good
   5   10   F   Yes   P    A   R2   20   Yes   43   Yes       136   Excellent
   6   41   F   No    P    O   R2   20   Yes   62   Yes       130   Excellent
   7   31   F   No    P    A   R2   20   No                   118   Good
   8   45   F   No    P    A   R0   20   No                   115   Good
   9   41   F   Yes   P    A   R2   20   No                   115   Good
  10   43   F   No    Re   A   R2   20   No                   114   Good
  11   50   F   Yes   P    A   R0   12   No                   109   Good
  12   64   F   No    P    A   R1   20   No                   106   Excellent
  13   53   F   Yes   P    O   R2   20   No                   105   Excellent
  14   28   F   Yes   P    O   R1   26   No                   97    Excellent
  15   49   M   No    P    O   R0   34   No                   91    Excellent
  16   22   M   No    Re   A   R2   32   No                   89    Excellent
  17   37   F   No    P    A   R2   32   No                   89    Good
  18   27   F   No    Re   A   R2   34   Yes   63   Refused   87    Poor
  19   22   M   No    Re   O   R2   34   Yes   62   Yes       84    Good
  20   31   F   No    P    O   R2   34   No                   83    Excellent
  21   45   M   No    P    A   R0   26   No                   82    Excellent
  22   34   F   Yes   P    A   R2   34   No                   69    Excellent
  23   52   M   No    P    A   R0   34   No                   52    Excellent

A Case

B Age

C Gender

D History of trauma

E Primary (P) vs. recurrent (Re)

F Surgery method

 A: Arthroscopic

 O: Open

G Resection status

 R0: No residual disease

 R1: Suspicion of residual disease

 R2: Gross residual disease

H Dose (Gy)

I Recurrence

J Disease-free interval (m)

K Salvage surgery

L Follow-up period (m)

M Final joint function

Treatment characteristics {#ss4}
-------------------------

17 patients underwent arthroscopic synovectomy and the other 6 underwent open synovectomy ([Table 1](#T1){ref-type="table"}). After cytoreductive surgery, 13 patients had obvious gross residual disease and 2 had suspected residual lesions. The remaining 8 patients, with no macroscopic tumor tissue left after surgery, received adjuvant RT. Patients were given postoperative RT if they had (1) large extra-articular and/or infiltrative disease (n = 10), (2) extensive local recurrences (n = 4), or (3) limited access to the affected joint during arthroscopic surgery (n = 9).

The median interval from the surgical procedure to the commencement of RT was 28 (18--48) days. All patients underwent RT using 4-MV or 6-MV photons with linear accelerators through two opposing fields (anterior to posterior and posterior to anterior) at a dose of 2 Gy per fraction once a day. Of the 23 patients, 13 (cases 1--13) were scheduled to receive 20 Gy by one physician and the other 10 were scheduled to receive 32--34 Gy by the other physician. 2 patients in each group (cases 1, 11, 14, and 21) refused to complete their planned radiotherapy. In four patients, a computed tomography-based 3-dimensional treatment planning system was used. Clinical target volume was defined as the tumor bed plus 5 cm margins superoinferiorly and the entire synovial cavity of the affected knee based on preoperative MRI and/or operation records. The planning target volume was defined from the clinical target volume with a margin of 10 mm.

Follow-up evaluation and statistical analysis {#ss5}
---------------------------------------------

Following RT, patients were routinely followed up by physical examination, with an MRI performed if symptoms became aggravated. Local recurrence was defined as new or increasing synovial lesions based on either MRI or pathological findings during salvage operations. The functional status of the involved joint was assessed as described previously ([@CIT0016], [@CIT0001]): excellent (no symptoms), good (minor symptoms), fair (moderate symptoms or joint dysfunction that did not interfere with daily activities), and poor (severe symptoms that interfered with daily activities). Complications of RT were recorded using the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.

The baseline follow-up date was the start of RT and the last follow-up date was the last hospital visit or date of telephone conversation. Local control was calculated from the baseline date to the date of first recurrence or last follow-up. Univariate analyses were performed to examine the effect on local control of age, sex, history of trauma, primary vs. recurrent disease, number of prior surgeries, and radiation dose (≤ 20 Gy vs. \> 20 Gy). All p-values were two-sided, and p-values \< 0.05 were considered statistically significant. SPSS software version 12.0K was used for all statistical analyses.

Results {#ss6}
=======

At a median follow-up time of 9 (0.8--12) years, 19 of the 23 patients showed no evidence of recurrence or persistent disease. 4 patients had local recurrences. 2 had received 20 Gy of external-beam RT and the others had received 34 Gy. Of these 4 patients, 3 regained local control after salvage synovectomy, whereas the remaining patient refused further surgery. The time interval between RT and diagnosis of recurrence was longer than 5 years in 3 of the 4 patients. Univariate analysis showed that age (≤ 37 vs. \> 37 years, p = 0.6), gender (p = 1), trauma history (p = 1), primary vs. recurrent (p = 0.1), number of prior surgeries (≤ 2 vs. \> 2, p = 0.3), and total dose of RT (≤ 20 Gy vs. \> 20 Gy, p = 1) were not associated with rate of local control. Patient and treatment characteristics were similar in the low-dose group and the conventional-dose group (≤ 20 Gy vs. \> 20 Gy) ([Table 2](#T2){ref-type="table"}).

###### 

Patient and treatment characteristics by radiation dose group

  --------------------------------------------------------------------------------------------------
  Variables                                                         ≤ 20 Gy\   \> 20 Gy\   p-value
                                                                    (n = 13)   (n = 10)    
  ----------------------------------------------------------------- ---------- ----------- ---------
  Mean age, years                                                   38         35          0.6

  Male : Female                                                     3:10       5:5         0.2

  History of trauma (yes : no)                                      5:8        2:8         0.4

  Primary : Recurrent                                               12:1       7:3         0.3

  Synovectomy method (open : arthroscopic)                          2:11       4:6         0.3

  Resection status (R0 : R1 : R2)**[^a^](#T2-N1){ref-type="fn"}**   5:1:7      3:1:6       0.9

  Recurrence (yes : no)                                             2:11       2:8         0.6

  7-year recurrence-free survival                                   83%        78%         0.8

  Final joint function (excellent : good : poor)                    5:8:0      7:2:1       0.1
  --------------------------------------------------------------------------------------------------

**^a^**Resection status: See Table 1 (G)

Of the 23 patients, 6 reported excellent joint function and 16 reported good joint function, whereas the patient who refused salvage synovectomy reported poor joint function. None of these patients, including the 3 who underwent salvage synovectomy after RT, experienced radiation-related early or late complications greater than grade 2. None developed any radiation-induced malignancy.

Discussion {#ss7}
==========

Local control was achieved in 19 of the 23 patients who underwent cytoreductive surgery followed by RT, with excellent or good joint function in all but 1 patient. Our findings are similar to those in previous reports ([@CIT0016], [@CIT0002], [@CIT0003], [@CIT0001], [@CIT0008], [@CIT0007]) ([Table 3](#T3){ref-type="table"}).

###### 

Previous studies of postoperative external beam radiotherapy

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                                     No. of sites\   Median dose\   Mean follow-up,\   Local control **[^a^](#T3-N1){ref-type="fn"}** of\
                                                             (knee)          (Gy)           years (range)      knee lesion (%)
  ---------------------------------------------------------- --------------- -------------- ------------------ ----------------------------------------------------
  O\'Sullivan **[^b^](#T3-N2){ref-type="fn"}** et al. 1995   14 (4)          35             5.8 (1.1--21)      100 **[^c^](#T3-N3){ref-type="fn"}**

  Blanco **[^b^](#T3-N2){ref-type="fn"}** et al. 2001        22 (22)         26             2.8 (2.2--6.3)     86

  Chin **[^d^](#T3-N4){ref-type="fn"}** et al. 2002          5 (5)           35             3.1 (2.7--3.5)     60

  Berger et al. 2007                                         7 (5)           40             2.4 (0.3--9.3)     100

  Horoschak et al. 2009                                      16 (12)         34             3.8 (0.7--15)      75 **[^f^](#T3-N6){ref-type="fn"}**

  Heyd **[^e^](#T3-N5){ref-type="fn"}** et al. 2010          41 (25)         36             NA (0.5--10≠)      95 **[^f^](#T3-N6){ref-type="fn"}**

  This study                                                 23 (23)         20             8.3 (0.8--12)      83
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: not available.

**^a^** crude rate.

**^b^** mainly using cobalt-60 irradiation.

**^c^** including 1 patient with stable disease.

**^d^** including postoperative external beam radiotherapy group only.

**^e^** One patient received radiotherapy with an orthovoltage X-ray machine and 2 patients with a cobalt-60 machine.

**^f^** Local control rate for the entire cohort.

There are several distinguishing aspects of our analysis. First, the follow-up time (median 9 years) was far longer than in most other studies. Long follow-up is required to detect local recurrence. For example, the average time to local recurrence in 4 patients ([@CIT0008]) was 3 years, and local recurrences have been reported as long as 17 years after primary treatment ([@CIT0017]). In our study, the 4 patients with recurrent disease had a median time to failure of 5 years, with 3 having disease-free intervals of longer than 5 years. Secondly, the median total dose of postoperative RT in our patients was 20 Gy, which was much lower than in other studies ([@CIT0016], [@CIT0002], [@CIT0003], [@CIT0011], [@CIT0001], [@CIT0008], [@CIT0007]). The doses as low as 20 Gy in 10 fractions came from the general prescribed doses for benign diseases such as thyroid ophthalmopathy ([@CIT0018]), orbital pseudotumor ([@CIT0010]), and heterotopic ossification ([@CIT0012]). Treatment of PVNS with total doses of \< 30 Gy has been associated with recurrence rates of 4--14% after median 3.5 years of follow-up ([@CIT0022], [@CIT0009], [@CIT0002]). Although other studies have used doses of 30--50 Gy ([@CIT0016], [@CIT0001], [@CIT0007]), there have been no studies showing dose-response relationships for postoperative RT in patients with PVNS. A recent study examining the correlation between total dose and local control in 41 patients from 14 departments failed to show a significant dose-effect relationship ([@CIT0007]). Of the 4 patients in our study who experienced recurrences, 2 had received 20 Gy RT whereas the other 2 had received 34 Gy, which indicates the same local control rate for the two treatment regimens. Thirdly, only patients with PNVS of the knee joint were included in our analysis. Despite the inconclusive relationship between location of PVNS and local control rate, local recurrence of PVNS of the knee has been reported more frequently than recurrences at other joints ([@CIT0020]).

We found similar local control rates in patients with primary PVNS and those with recurrent PVNS. Likewise, the number of previous surgeries had no effect on local control and functional outcomes. These findings are in accordance with those from a study of 24 patients with primary PVNS and 17 patients with recurrent PVNS ([@CIT0007]). Use of RT for benign disease such as PVNS may introduce concerns about the risks of functional impairment and radiation-induced malignancy. Of our patients, all but 1 showed excellent or good joint function. Similarly to other small-sized series, we did not observe any severe early or late radiation-related complications or secondary malignancies. To our knowledge, there have been no reports to date of radiation-induced malignancy after RT for PVNS.

The limitations of our study were its retrospective design, which may have introduced selection bias, and the small number of patients. Due to the low incidence of PVNS, it is almost impossible to perform large-scale prospective studies. To our knowledge, our study is the largest one so far of patients at a single center who received RT with modern technique for diffuse PVNS of the knee, and showing good local control.
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